Key Market Indicators
By 2028, Ukrainian insulin exports are projected to hit approximately $20 million, up from nearly $17 million in 2023, marking an average annual growth rate of 2.7%. Despite this growth, Ukraine's insulin supply has seen a slight decline of 0.9% per year since 2001. In 2023, Ukraine ranked 15th in global insulin exports, with Latvia slightly ahead at $17 million. France, Italy, and China occupied the second, third, and fourth spots, respectively. Conversely, Ukrainian insulin imports are expected to decrease to around $24 million by 2028, down from $25 million in 2023, reflecting an average annual decline of 0.7%. Since 2001, the country's insulin demand has similarly fallen by 0.9% per year.
